Milana Bazayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Milana Bazayeva has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Kenneth M. Merz
Center for Computational Life Sciences, Lerner Research Institute, The Cleveland Clinic, Cleveland, Ohio 44106, United States
4 shared publications - Zhen Li
The Cleveland Clinic
4 shared publications - Aimen Al‐Hilfi
Department of Chemical Engineering & Material Science Michigan State University East Lansing Michigan USA
2 shared publications - Akhil Shajan
The Cleveland Clinic
2 shared publications - Assaf A. Gilad
Department of Chemical Engineering & Material Science Michigan State University East Lansing Michigan USA
2 shared publications - Danil S. Kaliakin
Center for Computational Life Sciences, Lerner Research Institute
2 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
Quantum Computing-Enabled Ab Initio Molecular Dynamics Simulations
We demonstrate a quantum-classical workflow for ab initio molecular dynamics (AIMD) in which quantum measurements from a chemistry-inspired local unitary cluster Jastrow (LUCJ) ansatz are postprocessed using sample-based quantum diagonalization (SQD) to recover determinant subspaces and deliver energies and analytical nuclear gradients for dynamics. As an exact benchmark, we use full configuration interaction (FCI) in the STO-3G basis, enabling a direct assessment of the accuracy of SQD. In gas-phase benchmarks, SQD reproduces FCI energies and gradients to within 1 kcal mol–1 of the FCI reference and yields stable AIMD trajectories. In explicit-solvent QM/MM simulations, SQD retains this agreement, matching FCI energy fluctuations and RMS gradient profiles and reproducing solute–solvent structure as quantified by radial distribution functions. A 1 ps microcanonical trajectory in water, driven by 2000 independent calls to the quantum processor, conserves the total energy as well as the FCI reference. Overall, these benchmarks establish LUCJ + SQD as a practical route for integrating current quantum hardware into QM/MM molecular dynamics and provide an early demonstration of condensed-phase QM/MM dynamics driven by a quantum electronic-structure engine.
- 19 November 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
Open AccessQuantum Computing-Enabled Ab Initio Molecular Dynamics Simulations
We demonstrate a quantum-classical workflow for ab initio molecular dynamics (AIMD) in which quantum measurements from a chemistry-inspired local unitary cluster Jastrow (LUCJ) ansatz are postprocessed using sample-based quantum diagonalization (SQD) to recover determinant subspaces and deliver energies and analytical nuclear gradients for dynamics. As an exact benchmark, we use full configuration interaction (FCI) in the STO-3G basis, enabling a direct assessment of the accuracy of SQD. In gas-phase benchmarks, SQD reproduces FCI energies and gradients to within 1 kcal mol–1 of the FCI reference and yields stable AIMD trajectories. In explicit-solvent QM/MM simulations, SQD retains this agreement, matching FCI energy fluctuations and RMS gradient profiles and reproducing solute–solvent structure as quantified by radial distribution functions. A 1 ps microcanonical trajectory in water, driven by 2000 independent calls to the quantum processor, conserves the total energy as well as the FCI reference. Overall, these benchmarks establish LUCJ + SQD as a practical route for integrating current quantum hardware into QM/MM molecular dynamics and provide an early demonstration of condensed-phase QM/MM dynamics driven by a quantum electronic-structure engine.
- Open Access
- 15 June 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
- Vol. 22 (13) , 6835-6843
Quantum-Centric Alchemical Free Energy Calculations
In this work, we extended the book-ending framework with a hybrid quantum-classical workflow that incorporates configuration interaction (CI) calculations into alchemical free energy (AFE) predictions. In the book-ending approach, the Multistate Bennett Acceptance Ratio (MBAR) is applied along a coupling parameter λ to interpolate the system from molecular mechanics (MM) (λ = 0) to a quantum mechanics (QM) (λ = 1) description, and the resulting correction is added to the classically computed AFE. Building on the standard book-ending workflow, we developed an interface that introduces the CI contribution through two backends: (I) a classical PySCF-based backend; (II) a quantum-centric sample-based quantum diagonalization (SQD) method and its extended version (ext-SQD). This latter approach combines real quantum processing units (QPUs) with classical postprocessing to obtain CI energies and gradients. To validate the proposed infrastructure, we computed the book-ending corrections for the hydration free energies (HFEs) of three small organic molecules: ammonia, methane, and water. These benchmarks demonstrate that the CI-level electronic structure calculations, particularly those performed on a quantum hardware, can be naturally incorporated into AFE workflows. Specifically, the CI-corrected HFEs are in reasonable agreement with experimental values, supporting the feasibility of QPU-accelerated free energy predictions. As quantum devices continue to improve in scale and fidelity, they might offer a practical and scalable route to CI-quality electronic-structure data for systems that are challenging for classical approaches. Integrating these CI energies directly into QM/MM simulations could improve the accuracy of free energy methods for systems where electronic correlation plays a significant role, with potential relevance to large biomolecular systems, enhancing our ability to model molecular recognition, enzyme catalysis, and drug–receptor interactions.
- 15 June 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Theory and Computation
- Vol. 22 (13) , 6835-6843
Open AccessQuantum-Centric Alchemical Free Energy Calculations
In this work, we extended the book-ending framework with a hybrid quantum-classical workflow that incorporates configuration interaction (CI) calculations into alchemical free energy (AFE) predictions. In the book-ending approach, the Multistate Bennett Acceptance Ratio (MBAR) is applied along a coupling parameter λ to interpolate the system from molecular mechanics (MM) (λ = 0) to a quantum mechanics (QM) (λ = 1) description, and the resulting correction is added to the classically computed AFE. Building on the standard book-ending workflow, we developed an interface that introduces the CI contribution through two backends: (I) a classical PySCF-based backend; (II) a quantum-centric sample-based quantum diagonalization (SQD) method and its extended version (ext-SQD). This latter approach combines real quantum processing units (QPUs) with classical postprocessing to obtain CI energies and gradients. To validate the proposed infrastructure, we computed the book-ending corrections for the hydration free energies (HFEs) of three small organic molecules: ammonia, methane, and water. These benchmarks demonstrate that the CI-level electronic structure calculations, particularly those performed on a quantum hardware, can be naturally incorporated into AFE workflows. Specifically, the CI-corrected HFEs are in reasonable agreement with experimental values, supporting the feasibility of QPU-accelerated free energy predictions. As quantum devices continue to improve in scale and fidelity, they might offer a practical and scalable route to CI-quality electronic-structure data for systems that are challenging for classical approaches. Integrating these CI energies directly into QM/MM simulations could improve the accuracy of free energy methods for systems where electronic correlation plays a significant role, with potential relevance to large biomolecular systems, enhancing our ability to model molecular recognition, enzyme catalysis, and drug–receptor interactions.
- Open Access
- 18 November 2025
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 368 (1)
Biocatalytic Construction of a Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Nucleoside Probe: Synthesis and Evaluation of 5‐Methyl‐5,6‐Dihydrothymidine
Magnetic resonance imaging (MRI) is a cornerstone of modern clinical diagnostics, often enhanced by contrast agents. Traditionally, these agents are chemically synthesized, which can involve complex, costly, and environmentally unfriendly processes. Here, we report a novel biocatalytic approach for the efficient, safe, and eco‐friendly synthesis of 5‐methyl‐5,6‐dihydrothymidine (5‐MDHT), a potent chemical exchange saturation transfer (CEST)‐MRI probe for imaging in vivo expression of the Herpes Simplex Virus Type‐1 Thymidine Kinase (HSV1‐TK) reporter gene. We demonstrate that 5‐MDHT can be biosynthesized via one‐ or two‐step enzymatic reactions using human purine nucleoside phosphorylase (hPNPase) and the SgvM VAV SAM‐dependent methyltransferase. hPNPase catalyzed the base‐exchange reaction with catalytic efficiencies ( k cat /K M ) between 138 and 316 s −1 ·M −1 , while SgvM VAV methylation of 5,6‐dihydrothymidine yielded 5‐MDHT with a catalytic efficiency of 26 s −1 ·M −1 . Molecular dynamics simulations supported the enzymatic binding and selectivity observed experimentally. The resulting 5‐MDHT was validated using CEST‐MRI, showing a distinct exchangeable imino proton signal at 5.3 ppm. These findings highlight the chemo‐ and regioselectivity of the biocatalysts and establish biocatalysis as a viable platform for producing clinically relevant MRI contrast agents.
- 18 November 2025
- Published by Wiley in Advanced Synthesis & Catalysis
- Vol. 368 (1)
Open AccessBiocatalytic Construction of a Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Nucleoside Probe: Synthesis and Evaluation of 5‐Methyl‐5,6‐Dihydrothymidine
Magnetic resonance imaging (MRI) is a cornerstone of modern clinical diagnostics, often enhanced by contrast agents. Traditionally, these agents are chemically synthesized, which can involve complex, costly, and environmentally unfriendly processes. Here, we report a novel biocatalytic approach for the efficient, safe, and eco‐friendly synthesis of 5‐methyl‐5,6‐dihydrothymidine (5‐MDHT), a potent chemical exchange saturation transfer (CEST)‐MRI probe for imaging in vivo expression of the Herpes Simplex Virus Type‐1 Thymidine Kinase (HSV1‐TK) reporter gene. We demonstrate that 5‐MDHT can be biosynthesized via one‐ or two‐step enzymatic reactions using human purine nucleoside phosphorylase (hPNPase) and the SgvM VAV SAM‐dependent methyltransferase. hPNPase catalyzed the base‐exchange reaction with catalytic efficiencies ( k cat /K M ) between 138 and 316 s −1 ·M −1 , while SgvM VAV methylation of 5,6‐dihydrothymidine yielded 5‐MDHT with a catalytic efficiency of 26 s −1 ·M −1 . Molecular dynamics simulations supported the enzymatic binding and selectivity observed experimentally. The resulting 5‐MDHT was validated using CEST‐MRI, showing a distinct exchangeable imino proton signal at 5.3 ppm. These findings highlight the chemo‐ and regioselectivity of the biocatalysts and establish biocatalysis as a viable platform for producing clinically relevant MRI contrast agents.
- Open Access
Biocatalytic Construction of a CEST MRI Nucleoside Probe: Synthesis and Evaluation of 5-Methyl-5,6-dihydrothymidine
Magnetic Resonance Imaging (MRI) is a cornerstone of modern clinical diagnostics, often enhanced by contrast agents. Traditionally, these agents are chemically synthesized, which can involve complex, costly, and environmentally unfriendly processes. Here, we report a novel biocatalytic approach for the efficient, safe, and eco-friendly synthesis of 5-methyl-5,6-dihydrothymidine (5-MDHT), a potent Chemical Exchange Saturation Transfer (CEST) MRI probe for imaging in vivo expression of the Herpes Simplex Virus Type-1 Thymidine Kinase (HSV1-TK) reporter gene. We demonstrate that 5-MDHT can be biosynthesized via one- or two-step enzymatic reactions using human purine nucleoside phosphorylase (hPNPase) and the SgvM VAV SAM-dependent methyltransferase. hPNPase catalyzed the base-exchange reaction with catalytic efficiencies (k cat /K M ) between 138-316 s −1 M −1 , while SgvM VAV methylation of 5,6-dihydrothymidine yielded 5-MDHT with a catalytic efficiency of 26 s −1 M −1 . Molecular dynamics simulations supported the enzymatic binding and selectivity observed experimentally. The resulting 5-MDHT was validated using CEST-MRI, showing a distinct exchangeable imino proton signal at 5.3 ppm. These findings highlight the chemo- and regioselectivity of the biocatalysts and establish biocatalysis as a viable platform for producing clinically relevant MRI contrast agents.
Open AccessBiocatalytic Construction of a CEST MRI Nucleoside Probe: Synthesis and Evaluation of 5-Methyl-5,6-dihydrothymidine
Magnetic Resonance Imaging (MRI) is a cornerstone of modern clinical diagnostics, often enhanced by contrast agents. Traditionally, these agents are chemically synthesized, which can involve complex, costly, and environmentally unfriendly processes. Here, we report a novel biocatalytic approach for the efficient, safe, and eco-friendly synthesis of 5-methyl-5,6-dihydrothymidine (5-MDHT), a potent Chemical Exchange Saturation Transfer (CEST) MRI probe for imaging in vivo expression of the Herpes Simplex Virus Type-1 Thymidine Kinase (HSV1-TK) reporter gene. We demonstrate that 5-MDHT can be biosynthesized via one- or two-step enzymatic reactions using human purine nucleoside phosphorylase (hPNPase) and the SgvM VAV SAM-dependent methyltransferase. hPNPase catalyzed the base-exchange reaction with catalytic efficiencies (k cat /K M ) between 138-316 s −1 M −1 , while SgvM VAV methylation of 5,6-dihydrothymidine yielded 5-MDHT with a catalytic efficiency of 26 s −1 M −1 . Molecular dynamics simulations supported the enzymatic binding and selectivity observed experimentally. The resulting 5-MDHT was validated using CEST-MRI, showing a distinct exchangeable imino proton signal at 5.3 ppm. These findings highlight the chemo- and regioselectivity of the biocatalysts and establish biocatalysis as a viable platform for producing clinically relevant MRI contrast agents.